Pulmonary nodule other imaging studies: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 21: Line 21:
:*Low tumor metabolic activity
:*Low tumor metabolic activity
:*Hyperglycemia
:*Hyperglycemia


==References==
==References==
{{reflist|2}}
{{reflist|2}}

Revision as of 14:12, 21 March 2016

Pulmonary Nodule Microchapters

Home

Patient Information

Overview

Classification

Causes

Differentiating Pulmonary Nodule from Other Diseases

Epidemiology and Demographics

Screening

Natural history, Complications and Prognosis

Diagnosis

Evaluation of Solitary Pulmonary Nodule

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Pulmonary nodule other imaging studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pulmonary nodule other imaging studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary nodule other imaging studies

CDC on Pulmonary nodule other imaging studies

Pulmonary nodule other imaging studies in the news

Blogs on Pulmonary nodule other imaging studies

Directions to Hospitals Treating Solitary pulmonary nodule

Risk calculators and risk factors for Pulmonary nodule other imaging studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Overview

Other imaging studies include PET/CT scanning, which may be useful as a staging modality, detection of occult disease, and malignancy assessment.[1]

Other Imaging Findings

PET/CT

  • Other imaging studies include PET/CT scanning, which may be useful as a staging modality, detection of occult disease, and malignancy assessment.[1]
  • On PET/CT, findings of pulmonary nodule, may include:[2]
  • FDG uptake
  • Likely malignant
  • No FDG uptake
  • Likely benign

False negative results for pulmonary nodule characterization, include:

  • Small lesion size
  • Low tumor metabolic activity
  • Hyperglycemia

References

  1. 1.0 1.1 Lillington GA (1991). "Management of solitary pulmonary nodules". Dis Mon. 37 (5): 271–318. PMID 2019220.
  2. Steinert HC (2011). "PET and PET-CT of lung cancer". Methods Mol. Biol. 727: 33–51. doi:10.1007/978-1-61779-062-1_3. PMID 21331927.